Stocks
NeoGenomics, Inc.NEO
NASDAQHealthcareBiotechnology$17.37-1.25%
Price as of · delayed, not real-time
Specializing in cancer-focused genetic testing and clinical laboratory services, this company provides oncologists with diagnostic and prognostic information. Its comprehensive test menu and pharma services make it a key player in precision medicine. Investors monitor its growth in oncology testing and partnerships with biopharma firms.
Market Cap: $204.6M52W Range: $7.07-$19.76
Congressional Interest in NeoGenomics, Inc. (NEO)
5 members of Congress have disclosed 7 trades in NeoGenomics, Inc. (NEO), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 2 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
7
Unique Politicians
5
Buys
5
Sells
2
Who in Congress Is Trading NEO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-05-07 | Gilbert Cisneros | buy | $1K-$15K |
| 2022-03-30 | Dwight Evans | sell | $1K-$15K |
| 2021-12-30 | Deborah Ross | buy | $15K-$50K |
| 2021-11-09 | BOB GIBBS | sell | $1K-$15K |
| 2020-03-02 | Dwight Evans | buy | $1K-$15K |
| 2019-12-19 | BOB GIBBS | buy | $1K-$15K |
| 2017-03-29 | JAMES B. RENACCI | buy | $15K-$50K |